NSE · HIKAL.NS
Hikal Limited
₹214.55+₹10.15 (+4.97%)
Hikal Limited’s quoted price sits in the upper half of its reported 52-week range, 17.82% below the high.
Loading market information…
BSE · OXYGENTAPH.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 06:55 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Oxygenta Pharmaceutical Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.06% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Oxygenta Pharmaceutical Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Oxygenta Pharmaceutical Ltd. focuses on the formulation and production of active pharmaceutical ingredients. Their offerings specifically encompass medications used to treat ulcers and fight bacterial infections. The company commenced operations on November 27, 1990, and maintains its primary base in Hyderabad, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹214.55+₹10.15 (+4.97%)
Hikal Limited’s quoted price sits in the upper half of its reported 52-week range, 17.82% below the high.
₹87.69+₹7.95 (+9.97%)
Anuh Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 11.87% below the high.
₹281.00+₹3.00 (+1.08%)
Infinium Pharmachem Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.41% below the high.
₹110.75-₹0.09 (-0.08%)
Aarey Drugs & Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 3.53% below the high.
₹34.33-₹0.93 (-2.64%)
Syschem (India) Limited’s quoted price sits in the lower half of its reported 52-week range, 43.68% below the high.
₹139.95-₹2.60 (-1.82%)
Smruthi Organics Limited’s quoted price sits in the upper half of its reported 52-week range, 20.17% below the high.
₹31.40+₹0.95 (+3.12%)
Kimia Biosciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.45% below the high.
₹135.05-₹1.35 (-0.99%)
Parmax Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 2.91% below the high.
